Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 10, 2023
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
Tue, May 9, 2023
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
Vamil Divan Maintained (ANIP) at Strong Buy with Increased Target to $59 on, May 9th, 2023
Vamil Divan of Guggenheim, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $55 to $59 on, May 9th, 2023.
Vamil, nor any peers, have made any analyst calls on ANIP in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30